Resumption of treatment with penicillamine after proteinuria.

AUTOR(ES)

Hill, H

RESUMO

Penicillamine has been successfully reintroduced and continued for a minimum of 13 months in 5 patients who developed proteinuria during the first course of the drug. The daily maintenance dose during the second course was 150--250 mg taken midway between 2 meals. Proteinuria did not recur; no significant excretion of fibrin degradation products occurred; complement, urea, creatinine, and serum albumin remained within normal limits. Urine microscopy showed no abnormality.

Documentos Relacionados

• Thrombolytic treatment and proteinuria.
• Gold treatment for rheumatoid arthritis: reassurance on proteinuria.
• Increased glycosphingolipid excretion associated with proteinuria.
• The clinical significance of Bence Jones proteinuria.
• STUDIES ON HUMAN PROTEINURIA. II. SOME CHARACTERISTICS OF THE GAMMA GLOBULINS EXCRETED IN NORMAL, EXERCISE, POSTURAL, AND NEPHROTIC PROTEINURIA*